Xiaosong Li

647 total citations
18 papers, 469 citations indexed

About

Xiaosong Li is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Immunology. According to data from OpenAlex, Xiaosong Li has authored 18 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Biomedical Engineering and 6 papers in Immunology. Recurrent topics in Xiaosong Li's work include Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (6 papers) and Photodynamic Therapy Research Studies (5 papers). Xiaosong Li is often cited by papers focused on Nanoplatforms for cancer theranostics (8 papers), Immunotherapy and Immune Responses (6 papers) and Photodynamic Therapy Research Studies (5 papers). Xiaosong Li collaborates with scholars based in China, United States and Bahamas. Xiaosong Li's co-authors include Wei R. Chen, Robert E. Nordquist, Wenyang Jiang, Yuyan Xiong, Yuejin Yang, Yan Fu, Henry H. Le, Mark F. Naylor, Cynthia K. Murray and T. Kent Teague and has published in prestigious journals such as Medicine, IEEE Journal of Selected Topics in Quantum Electronics and Nanomedicine Nanotechnology Biology and Medicine.

In The Last Decade

Xiaosong Li

17 papers receiving 465 citations

Peers

Xiaosong Li
Maureen Aliru United States
Gurpreet Lamba United States
Elizabeth M. Gillies United States
Peter Flynn Australia
Maureen Aliru United States
Xiaosong Li
Citations per year, relative to Xiaosong Li Xiaosong Li (= 1×) peers Maureen Aliru

Countries citing papers authored by Xiaosong Li

Since Specialization
Citations

This map shows the geographic impact of Xiaosong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosong Li more than expected).

Fields of papers citing papers by Xiaosong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaosong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosong Li. The network helps show where Xiaosong Li may publish in the future.

Co-authorship network of co-authors of Xiaosong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaosong Li. A scholar is included among the top collaborators of Xiaosong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaosong Li. Xiaosong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cui, Yingshu, Yuanyuan Xu, Yi Li, et al.. (2023). Antibody Drug Conjugates of Near-Infrared Photoimmunotherapy (NIR-PIT) in Breast Cancers. Technology in Cancer Research & Treatment. 22. 2213887880–2213887880. 9 indexed citations
2.
Zhao, Yibing, Yuanyuan Xu, Bo Wang, et al.. (2023). Anti-PD1 antibody and not anti-LAG-3 antibody improves the antitumor effect of photodynamic therapy for treating metastatic breast cancer. Journal of Innovative Optical Health Sciences. 17(1).
3.
Liu, Shanshan, Ruixiang Song, Xiaosong Li, & Feifan Zhou. (2021). Synergistic therapeutic strategies for cancer treatment based on nanophototherapy. Nanophotonics. 10(12). 3391–3395. 9 indexed citations
4.
Jiang, Wenyang, Yuyan Xiong, Xiaosong Li, & Yuejin Yang. (2021). Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles. Frontiers in Cardiovascular Medicine. 8. 715258–715258. 75 indexed citations
5.
Bi, Yiliang, et al.. (2021). Research Progress of Autofluorescence Imaging Technology in the Diagnosis of Early Gastrointestinal Tumors. Cancer Control. 28. 2895462385–2895462385. 9 indexed citations
6.
Hu, Jia, Yan Fu, Dianjun Chen, et al.. (2020). Acquired multiple mutations ALK I1171N, L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report. Therapeutic Advances in Respiratory Disease. 14. 3272670810–3272670810. 15 indexed citations
7.
Xu, Yuanyuan, Feifan Zhou, Ning Dong, et al.. (2019). Mathematical simulation of temperature distribution in tumor tissue and surrounding healthy tissue treated by laser combined with indocyanine green. Theoretical Biology and Medical Modelling. 16(1). 12–12. 27 indexed citations
8.
Li, Yong, Xiaosong Li, Austin Doughty, et al.. (2019). Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer. Nanomedicine Nanotechnology Biology and Medicine. 18. 44–53. 59 indexed citations
9.
Bi, Yiliang, Min Min, Fengmei Zhang, & Xiaosong Li. (2019). The Characteristics of Blue Laser Imaging and the Application in Diagnosis of Early Digestive Tract Cancer. Technology in Cancer Research & Treatment. 18. 1078093525–1078093525. 8 indexed citations
10.
Xu, Yuanyuan, et al.. (2019). A new palliative treatment for blastic plasmacytoid dendritic cell neoplasm: a case report and review of the literature. Journal of International Medical Research. 47(10). 5281–5288. 2 indexed citations
11.
Wang, Dong‐Xin, et al.. (2019). Characteristics of help-seeking behavior among bipolar disorder patients. Medicine. 98(46). e17687–e17687. 4 indexed citations
12.
Li, Xiaosong, Nan Du, Haijun Li, et al.. (2017). Photothermal therapy combined with dinitrophenyl hapten for the treatment of late stage malignant melanoma. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 10065. 1006505–1006505. 1 indexed citations
13.
Fu, Yan, Hui Zhao, Jia Hu, et al.. (2015). Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib.. PubMed. 8(5). 8288–94. 34 indexed citations
14.
Du, Nan, et al.. (2015). Novel pH-sensitive nanoformulated docetaxel as a potential therapeutic strategy for the treatment of cholangiocarcinoma. Journal of Nanobiotechnology. 13(1). 17–17. 17 indexed citations
15.
Du, Nan, Xiaosong Li, Fang Li, et al.. (2013). Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer-mediated malignant pleural effusion. Oncology Reports. 29(6). 2332–2340. 74 indexed citations
16.
Li, Xiaosong, Min Min, Ying Gu, et al.. (2012). Laser Immunotherapy: Concept, Possible Mechanism, Clinical Applications, and Recent Experimental Results. IEEE Journal of Selected Topics in Quantum Electronics. 18(4). 1434–1438. 11 indexed citations
17.
Li, Xiaosong, Mark F. Naylor, Henry H. Le, et al.. (2010). Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients. Cancer Biology & Therapy. 10(11). 1081–1087. 104 indexed citations
18.
Li, Xiaosong, Henry H. Le, Roman F. Wolf, et al.. (2010). Long-Term Effect on EMT6 Tumors in Mice Induced by Combination of Laser Immunotherapy and Surgery. Integrative Cancer Therapies. 10(4). 368–373. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026